Forman Stephen J. has filed 8 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 10000 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. ($LIXT) on June 30, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 30, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Forman Stephen J. | Director | A | Options to Purchase Common Stock | 10000 | $0.00 | 72,423.0000 | 2,249,290 | 16.02% | 0.44% |
| June 30, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Forman Stephen J. | Director | A | Options to Purchase Common Stock | 7754 | $0.00 | 70,177.0000 | 2,249,290 | 12.42% | 0.34% |
| March 31, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Forman Stephen J. | Director | A | Options to Purchase Common Stock | 5851 | $0.00 | 62,423.0000 | 2,249,290 | 10.34% | 0.26% |
| Jan. 20, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Forman Stephen J. | Director | A | Options to Purchase Common Stock | 3030 | $0.00 | 56,572.0000 | 2,249,290 | 5.66% | 0.13% |
| Sept. 30, 2024 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Forman Stephen J. | Director | A | Options to Purchase Common Stock | 3858 | $0.00 | 53,542.0000 | 1,915,838 | 7.77% | 0.20% |
| June 30, 2024 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Forman Stephen J. | Director | A | Options to Purchase Common Stock | 10000 | $0.00 | 46,666.0000 | 1,915,838 | 27.27% | 0.52% |
| June 30, 2024 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Forman Stephen J. | Director | A | Options to Purchase Common Stock | 3018 | $0.00 | 39,684.0000 | 1,915,838 | 8.23% | 0.16% |
| June 30, 2023 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Forman Stephen J. | Director | A | Options to Purchase Common Stock | 10000 | $0.00 | 36,666.0000 | 0 | 37.50% | 0.00% |